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Background: In the absence of reliable data, antenatal HIV surveillance has been used to monitor the HIV epidemic
since the late 1980s. Currently, routine data from Prevention of Mother-to-child HIV transmission (PMTCT)
programmes are increasingly available. Evaluating whether the PMTCT programme reports provide comparable HIV
prevalence estimates with the antenatal surveillance reports is important. In this study, we compared HIV
prevalence estimates from routine PMTCT programme and antenatal surveillance in Addis Ababa with the aim to
come up with evidence based recommendation.
Methods: Summary data were collected from PMTCT programmes and antenatal surveillance reports within the
catchment of Addis Ababa. The PMTCT programme data were obtained from routine monthly reports from 2004 to
2009 and from published antenatal HIV surveillance reports from 2003 to 2009. Data were analysed using
descriptive statistics.
Results: In Addis Ababa, PMTCT sites had increased from six in 2004 to 54 in 2009. The site expansion was
accompanied by an increased number of women testing. There were marked increases in the rate of HIV testing
following the introduction of routine opt-out HIV testing approach. Paralleling these increases, the HIV prevalence
showed a steady decline from 10.0% in 2004 to 4.5% in 2009. There were five antenatal surveillance sites from 2003
to 2007 in Addis Ababa and they increased to seven by 2009. Four rounds of surveillance data from five sites
showed a declining trend in HIV prevalence over the years. The overall antenatal surveillance data also showed that
the HIV prevalence among antenatal attendees had declined from 12.4% in 2003 to 5.5% in 2009. The HIV
prevalence estimates from PMTCT programme were 6.2% and 4.5% and from antenatal surveillance 6.1 and 5.5% in
2008 and 2009 respectively.
Conclusions: There were consistent HIV prevalence estimates from PMTCT programme and from antenatal
surveillance reports. Both data sources showed a marked decline in HIV prevalence among antenatal care attendees
in Addis Ababa. This study concludes that the routine data from the PMTCT programmes in Addis Ababa provides
comparable HIV prevalence estimates with antenatal HIV surveillance data and could be used for monitoring trends.
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Antenatal HIV surveillance is widely used to monitor
trends in HIV prevalence and to model incidence rates
[1-6]. It has also been used to direct efforts towards
HIV/AIDS prevention and control in the absence of reli-
able data for HIV/AIDS programme monitoring and
evaluation. For antenatal surveillance, blood samples col-
lected from pregnant women for routine syphilis tests
are used. Since the samples are unlinked and anonym-
ous, participation bias is unlikely [6,7].
Despite its popularity, there are ethical and methodo-
logical concerns about antenatal HIV surveillance which
remain unsolved [6,7]. From an ethical point of view, the
antenatal surveillance does not offer direct individual
level benefits to the women since the test is anonymous
and unlinked. The major methodological issue includes
its reliance on samples collected from a few selected
sites for a certain period in a year, lack of representation
of private health facilities, sites are often urban biased
and the sample sizes are often arguable. Not being part
of routine activity, costs associated with antenatal sur-
veillance system are additional concerns. Prabhu et al.
have done an economic evaluation in Zanzibar to esti-
mate incremental costs of antenatal surveillance using
routine Prevention of mother-to-child HIV transmission
(PMTCT) programme data and reported that routine
PMTCT report provides considerable cost saving com-
pared to antenatal surveillance [8].
However, although no additional costs are incurred in
routine PMTCT programme reports, their validity is
affected by low antenatal care coverage, low rate of HIV
test acceptance and lack of standardized recording and
reporting system.
In Ethiopia, following the rapid scaling up of PMTCT
programmes, large proportions of pregnant women have
been reached [9,10]. At the national level the number of
health facilities offering PMTCT services in 2009 was over
10 times higher than the number of antenatal surveillance
sites i.e. 1 352 vs 114 respectively. There are large varia-
tions in coverage of antenatal care and uptake of HIV
testing in PMTCT programmes across the regions in Ethi-
opia. The capital Addis Ababa, has the highest antenatal
coverage as well as the highest uptake of antenatal HIV
testing. In 2012 Ethiopian Demographic and Health Sur-
vey reports, 94% pregnant women in Addis Ababa receive
antenatal care from skilled health care providers and 84%
receive skilled birth care [11]. Moreover, about 85% ante-
natal attendees receive HIV testing [10]. In 2009, there
were 54 PMTCT sites and only seven antenatal HIV sur-
veillance sites across the city. All the seven surveillance
sites also provided PMTCT programmes.
Therefore, this study compared HIV prevalence esti-
mates from routine PMTCT programmes and antenatal
surveillance in Addis Ababa using summary reports. Thestudy used Addis Ababa as a case for preliminary ana-
lysis whether routine PMTCT programme reports have
a potential to monitor HIV prevalence trends and to
come up with evidence based recommendations.
Methods
This retrospective study used PMTCT programme and
antenatal HIV surveillance reports for the whole catch-
ment of Addis Ababa. Addis Ababa is administratively
divided into 10 sub-cities. Under each sub-city there are
public and private health facilities reporting their routine
monthly activities including PMTCT. Five public health
centres from 2003 to 2007 and seven in 2009 have been
dual sites for regular antenatal surveillance and PMTCT
programme. At the sub-city level, monthly PMTCT
reports from all health facilities are compiled together
and reported to the City Council Health Bureau. This
study compiled routine monthly PMTCT reports from
all the sub-cities and the antenatal surveillance reports
from published source.
PMTCT programme reports
Free PMTCT programme was launched in Addis Ababa
in 2004 in six selected public health centres located in
three sub-cities. By 2005, the programme was expanded
to all the ten sub-cities but the expansion took place at
different times. The programme has continued to scale
up and from 2007 it has expanded into private health
facilities. Currently, almost all health facilities providing
maternity care services in the city also provide PMTCT
services.
In early 2008, the HIV testing approach was shifted
from opt-in (voluntary testing) to opt-out (routine test-
ing) [10]. In the programme HIV counselling and testing
is offered as part of antenatal care for all pregnant
women. PMTCT providers in the antenatal clinics per-
form a rapid HIV testing from a finger prick blood
sample. There is re-testing of HIV positive samples for
verification before informing the test result to the
woman. In cases of inconsistencies between first and
second tests a third tie breaker test will be used. Follow-
ing the testing, the women’s HIV test result and other
PMTCT information are recorded in PMTCT logbooks
at the facilities. End of each month, PMTCT service pro-
viders at the health facilities record summary PMTCT
reports on standard PMTCT format distributed by the
sub-cities. This format include summary data on the
number of first time antenatal attendees, number of
revisit antenatal attendees, number of women who
received pre-test HIV counselling, number of women
who received HIV testing, number of women who
received post-test counselling and number of women
tested positive [10]. These summary data were all ana-
lysed in this study.
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specific data in the sub-cities, the HIV prevalence esti-
mates were calculated from summary monthly reports.
The monthly PMTCT reports from 2004 to 2009 were
collected from all the 10 sub-cities. For the purpose of
data validation, reports were also collected from Addis
Ababa City Council Health Bureau and Intra-Health (an
NGO working on PMTCT). During the data collection,
3 months reports were missing in one of the sub-city
(Lideta) but we collected them from the service outlets.
Of the collected monthly reports, 6.5% had some incom-
plete information.
Antenatal surveillance reports
Summary antenatal HIV surveillance data was obtained
from the 2007 and 2009 rounds antenatal HIV surveil-
lance report published by the Federal Ministry of Health
of Ethiopia and Ethiopian Health and Nutrition Research
and from AIDS in Ethiopia fifth and sixth reports
[12-15]. Ethiopia uses antenatal surveillance for monitor-
ing HIV prevalence trends and modelling incidence
across the county. Surveillance sites are selected based
on set of criteria including suitability for antenatal care,
accessible functional laboratory, adequate client volume,
sustainable supply for syphilis screening and routine
blood drawing services for syphilis/haemoglobin testing.
Three to four hundred left over blood samples for rou-
tine syphilis test are used. The sample collection period
is 12 weeks from urban sites whereas for 20 weeks from
rural sites. The samples are anonymous and unlinked
collected consecutively from 15–49 years old antenatal
attendees during the surveillance period. After collec-
tion, specimens are transported to regional testing la-
boratories and screened using Vironostika HIV antigen/
antibody Enzyme Immunosorbent Assay (EIA). All HIV
positive specimens are re-tested using Murex HIV anti-
gen/antibody EIA [12].
The first antenatal surveillance site was established
in 1989 in one public health centre [16]. In 1989 the
HIV prevalence among antenatal attendees was 4.6%
which has peaked to 21.2% in 1995 and followed by
steady decline since then [12]. From 1997 more sites
were added but limited to public health facilities. SinceTable 1 Number of antenatal care attendees in health facilitie
HIV prevalence from 2004 to 2009 in Addis Ababa
Year Number of antenatal attendee in PMTCT facilities Numb
2004 6208
2005 46272
2006 58510
2007 54502
2008 47591
2009 345852003, there were five health centres namely Akaki,
Gulele, Higher 23, Kazanchis and Teklehymanot con-
ducting regular antenatal surveillance while Kolfe and
Kotebe health centres were included from 2009. In this
study, for the trend analysis the five health centres which
had complete reports from 2003 to 2009 (four consecu-
tive) rounds were used.
Ethical considerations and data analysis
Ethical clearance was obtained from Addis Ababa City
Council Health Bureau and from the Regional committee
for Medical Research Ethics in Western Norway. Study
permits were obtained from respective sub-cities health
bureaus and health facilities. Data were double en-
tered and checked for consistencies before analysis. The
monthly PMTCT reports were entered in Microsoft Excel
spread sheet and analyzed using Pivotal table and Pivotal
chart report. Data analyses were done using descriptive
statistics.
Results
The PMTCT reports
In Addis Ababa, as the number of facilities providing
PMTCT services increased from six in 2004 to 54 in
2009, the number of women receiving HIV testing also
showed a year by year increase (Table 1). The reports in
2009 compiled data for 9 months, and gave lower num-
ber of women tested in 2009 than in 2008. From 2004
up to 2007 antenatal HIV counselling and testing was
offered in voluntary basis (opt-in approach), and the
antenatal attendees tested for HIV were 66% in 2004,
33% in 2005, 40% in 2006 and 52% in 2007. Following
the introduction of routine opt-out testing approach,
75% of the antennal attendees in 2008 and 84% in 2009
were tested for HIV (Table 1). Across the year the HIV
prevalence showed steady decline from 10.0% in 2004 to
4.5% in 2009 (Figure 1).
Antenatal surveillance reports
In Addis Ababa, five health centres from 2003–2007 and
seven in 2009 had conducted regular antenatal HIV
surveillance. In total 1 452 pregnant women in 2003, 1
939 in 2005, 1 517 in 2007 and 2 754 were tested fors providing PMTCT services, those tested for HIV and the
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Figure 1 Comparing HIV prevalence estimates from PMTCT and antenatal surveillance reports from 2003–2009 in Addis Ababa.
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the five health centres which participated in four con-
secutive rounds of surveillance showed declining trends
in HIV prevalence (Table 2). The two antenatal HIV sur-
veillance sites added in 2009 i.e. Kolfe and Kotebe
reported a lower HIV prevalence than those who had
been reporting for years. The overall HIV prevalence
had declined across the years from 12.4% in 2003 to
12.1% in 2005 then 6.2% in 2007 and reached 5.5% in
2009 (Figure 1).
Discussion
In this study, we compared HIV prevalence estimates
from routine PMTCT programme and antenatal HIV
surveillance in Addis Ababa with the intention to come
up with evidence based recommendations on the poten-
tial of PMTCT programme data for antenatal HIV sur-
veillance. The proportion of women testing in PMTCT
programme increased markedly, particularly following
the introduction of the opt-out HIV testing approach.
According to the summary reports, the HIV prevalence
among pregnant women in Addis Ababa had shownTable 2 Antenatal HIV surveillance reports stratified by healt
Health
centre
Total number of
2003 200
Akaki 304 (10.9) 428 (9
Gulele 306 (12.4) 393 (1
Higher 23 306 (11.8) 444 (1
Kazanchis 284 (11.6) 341 (1
Teklehymanot 252 (15.1) 333 (1
Kolfe
Kotebesteady decline. Four years trend data from the five health
centres that conducted regular antenatal HIV surveil-
lance also confirmed the decline. The HIV prevalence
estimates obtained from the PMTCT programmes and
the antenatal surveillance showed consistencies. In con-
clusion, the routine PMTCT programme report in Addis
Ababa can provide comparable estimate with that of
antenatal HIV surveillance report and has potential to
monitor HIV prevalence trends.
Our findings showed that the proportion of women
testing in PMTCT programme increased markedly espe-
cially following the introduction of the opt-out HIV test-
ing approach. Consistent with our findings, several
studies from resource poor settings including Ethiopia
have reported dramatic increases in the proportions of
women testing in PMTCT programmes following the
WHO policy statement on routine opt-out HIV testing
approach in 2004 [10,17-19]. The data obtained from
the different sources reported that the HIV prevalence
among pregnant women in Addis Ababa had shown
steady decline. This is in agreement with a paper of
Mirkuzie et al., where a declining HIV prevalence amongh centres from 2003 - 2009
women tested for HIV (HIV prevalence in%)
5 2007 2009
.1) 309 (7.8) 420 (7.4)
3.0) 310 (6.1) 310 (8.7)
0.1) 341 (5.2) 333 (5.4)
6.7) 283 (5.7) 497 (4.4)
1.7) 274 (6.2) 304 (6.9)
497 (2.2)
393 (3.8)
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[10]. In the 2011 UNAIDS reports, the HIV epidemic in
Ethiopia among 15–24 years old pregnant women show
82% decline in 2010 compared to 2001 [20].
In our study, the HIV prevalence estimates from the
PMTCT programmes and from the antenatal HIV surveil-
lance showed high consistency in 2008 and 2009, where
the number of women testing in PMTCT programme
increased following the introduction of opt-out testing ap-
proach. Similar reports were documented in Cameroon
with 69% of women testing in PMTCT programme, com-
parable HIV prevalence estimates were reported i.e. 7.8%
from PMTCT programme and 7.3% from antenatal sur-
veillance. Also, in Botswana when HIV testing in PMTCT
programme was >95% between 2005 and 2007, the HIV
prevalence estimates from PMTCT programme and ante-
natal surveillance were similar [21]. In India with 68% rate
of HIV testing in PMTCT programme no statistically sig-
nificant difference was observed between the two esti-
mates [2]. In our study, when the rate of HIV testing in
PMTCT programme was lowest; 33% in 2005 there
appeared to be disparities between the two estimates, 8.8%
in the PMTCT programme and 12.1% in the antenatal
surveillance (Figure 1). Using the 2002 and 2003 PMTCT
reports in Uganda, Mpairwe and colleagues also reported
higher HIV prevalence from PMTCT programme than
antenatal surveillance with less than 70% of the antenatal
attendees testing for HIV in the PMTCT programme but
no differences with 70% or more of the antenatal atten-
dees testing [22].
Marsh et al. have analysed papers from seven sub-
Sahara African countries; when the rate of HIV testing is
low the possibility of participation bias in PMTCT pro-
grammes is high due to perception of risks and differ-
ences in demographic characteristics. Participation bias
can also happen if the PMTCT programme is newly
established as high risk cases are more likely to take ad-
vantage of the HIV testing [21]. In general, participation
bias is less likely where routine opt-out HIV approach is
properly implemented. Routine antenatal HIV testing
has been implemented in Addis Ababa since early 2008
and accompanied by significant improvement in the rate
of HIV testing in PMTCT programmes, and in other
resource poor settings [10,17,18]. Marsh and colleagues
also assessed the comparability of the two estimates;
papers from Cameroon and Botswana asserted the com-
parability of the two estimates and suggesting its poten-
tial utility for HIV monitoring. In contrast, although the
overall HIV prevalence estimates appear to be similar
in Kenya, Uganda and Zimbabwe there are large differ-
ences at clinic level and are discouraging the replace-
ment of PMTCT programme estimate for the antenatal
surveillance estimate [21]. Consistent with the latter
observations, a report from 43 dual PMTCT andsurveillance sites in Ethiopia showed comparable over-
all HIV prevalence estimates but large differences at
clinic level [12].
Although all these studies acknowledged the potentials
of the PMTCT programme data for antenatal HIV surveil-
lance purposes, they all agreed that currently its quality is
not good enough to be used for surveillance. The major
concerns are lack of uniform registers, reporting formats
and reporting date and missing or inconsistent training
among those who are doing the routine reporting. Issues
related to HIV testing include lack of standard testing
algorithm, unreliable supply of test kits and other logistics,
variable training among professionals who are doing the
testing and lack of quality control system [12,21]. The lack
of international consensus on how to make routine
PMTCT reports suitable for antenatal surveillance is an-
other concern [21].
As the HIV epidemic is maturing and is taking a
chronic course, it is imperative to revisit existing strat-
egies to maximize efficiency of the control programme
and to direct resources where it is most needed. Larson
and colleagues in their paper highlighted the need for
strategic responses, including integration of AIDS inter-
vention with other relevant health programmes, and the
need for regular systematic programme monitoring and
evaluation [23]. Currently, the Global Health Initiative
(GHI) is investing on health system strengthening for
optimal health gain and is supporting the Ethiopian gov-
ernment [24]. Being one of the building blocks of the
health system, improving monitoring and evaluation of
programme activities are emphasized.
For optimal monitoring and evaluation, Health Manage-
ment Information System (HMIS) has been implemented
in Addis Ababa for routine programme reporting [25].
The HMIS use standard computerized registers and
reporting system and it can be an asset for standardizing
the PMTCT reports. Even before the scaling up of the
HMIS across the city, the quality of the PMTCT reports
seem to be good; over 90% the reports from the sub-cities
were complete. Moreover, standard antenatal HIV testing
algorithm recommended in the 2007 Ethiopian PMTCT
guidelines has been used in Addis Ababa, and could help
to minimize potential inconsistencies at the level of sam-
ple collection and processing [26].
In line with these arguments, Addis Ababa seems to
quality to use routine PMTCT programme reports for
surveillance purpose and can be a pilot site for Ethiopia.
Nonetheless, continuing the regular antenatal HIV sur-
veillance in parallel for some time could help to validate
the quality of PMTCT programme data until it gets per-
fected. Meanwhile, issues related to supply of test kits
and logistics, particularly the need for continuous in-
service training to minimize gaps due to staff turnover
need to be emphasized.
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ness analysis would be some major limitations of the
study. However, to ensure quality, the PMTCT reports
obtained from the sub-cities were validated with reports
from the City Council Health Bureau and from Intra-
Health and they were consistent. For ensuring data com-
pleteness, missing monthly reports were collected from
service outlets. The study could have benefited from cost
effectiveness analysis to show how much saving the
health system can make when antenatal surveillance is
phased out and investment is diverted for generating
quality PMTCT programme reports. We used summary
reports from PMTCT reporting formats aggregated at
the sub-city level and summarized HIV prevalence
reports, and hence we lack individual level and clinic
based data to assess differences in HIV prevalence by
socio-demographic variables and to assess differences
among clinics.
Conclusions
There is consistency in the HIV prevalence estimates
from PMTCT programme and from antenatal HIV sur-
veillance when antenatal HIV testing is routine standard
of care. Our study underscores the validity and potential
of the PMTCT programme estimates for monitoring
trends in HIV/AIDS prevalence and to guide prevention
and control efforts and are supported by previous stud-
ies. High PMTCT programme coverage, high rate of
HIV testing in PMTCT programmes and good quality
data are pre-requisites for successful transition from
antenatal surveillance to PMTCT programme estimates
whereby Addis Ababa seems to fulfil all. We recommend
the Addis Ababa City Council Health Bureau and the re-
spective sub-cities to use estimates from PMTCT
programme reports for the purpose of HIV surveillance
with continuous data quality monitoring using HMIS.
Taking into account these results Ethiopia should con-
tinue to assess PMTCT data in order to replace ANC
surveillance.
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